Helus Pharma (HELP) vs Immix Biopharma (IMMX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Immix Biopharma (IMMX) has outperformed Helus Pharma (HELP) over the past year, gaining 278.1% versus a gain of 73.1%. Immix Biopharma is the larger company by market cap ($786.7 million vs $767.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HELP | IMMX |
|---|---|---|
| Share price | $10.51 | $9.49 |
| Market cap | $767.86M | $786.75M |
| 1-day change | -2.32% | -1.56% |
| YTD return | +28.48% | +81.45% |
| 1-year return | +73.15% | +278.09% |
| 5-year return | -85.96% | — |
| EPS (TTM) | $-4.15 | $-0.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.15 | $15.10 |
| 52-week low | $3.76 | $2.31 |
| Distance from 52-week high | -30.63% | -37.15% |
| Average volume | 1.79M | 1.66M |
| Shares outstanding | 73.06M | 82.90M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMX has outperformed HELP by 204.9 percentage points over the past year.
HELP vs IMMX FAQ
Which is bigger, Helus Pharma or Immix Biopharma?
Immix Biopharma (IMMX) is larger, with a market capitalization of $786.75M compared with $767.86M for Helus Pharma (HELP).
Which stock has performed better over the past year, HELP or IMMX?
IMMX returned +278.09% over the past 12 months, compared with +73.15% for HELP (price return, excluding dividends). Past performance does not predict future results.
Are Helus Pharma and Immix Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.